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The importance of zinc in biology is evi-
denced by the growing number of disease 
states that directly involve aberrant lev-
els of zinc, including neurodegeneration, 
inflammation, diabetes, cancer and more. 
Zinc is a component of an estimated 10% 
of all proteins1 and has a well-established 
role in regulation of gene expression, 
primarily through activation of metal-
responsive transcription factor-1 (MTF1) 
as well as an array of trans-acting fac-
tors.2 Recently, attention has been drawn 
to the fact that free Zn2+ in cells has also 
non-genomic signaling effects that can be 
evoked through extracellular stimuli.3,4 
The Zn2+ ion therefore fulfils the criteria 
for being a second messenger.5 However, 
delivery of its second messenger role 
would require three key components to be 
present: (1) transmission of the extracel-
lular stimuli to the intracellular machin-
ery, (2) mechanism for the gated release 
of Zn2+ into the cytosol through modifica-
tion of an effector molecule and (3) the 
translation of Zn2+ flux into altered activity 
in downstream targets. Our recent finding 
that a zinc channel, ZIP7 (SLC39A7), can 
be activated by phosphorylation by pro-
tein kinase CK2 as a direct result of an 
extracellular stimulation provides the cen-
tral component of this pathway.6
ZIP7 is the only ZIP zinc channel 
known to reside in the membrane of the 
endoplasmic reticulum.7 In response to 
epidermal growth factor (EGF) stimula-
tion, CK2 activates ZIP7 through serine 
phosphorylation, resulting in release of 
free Zn2+ ions into the cytosol.6 The con-
sequential rise in cytosolic Zn2+ concen-
tration activates protein kinases involved 
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in cell proliferation, which results in 
increased cell migration. ZIP7 is ubiq-
uitously expressed in cells unlike many 
other ZIP channels which are often 
expressed in a tissue-specific manner. This 
suggests that ZIP7 may be a gatekeeper 
for cytosolic Zn2+ release and control Zn2+ 
signals in multiple cell types.8 The targets 
directly affected by zinc signals remain to 
be mapped, but protein tyrosine phospha-
tases (PTP) seem to be a family of pro-
teins that are particularly affected by an 
increase in [Zn2+]
i
.4 In a recent study, it 
was shown that a particular PTP, PTPβ, 
is inhibited by Zn2+ with a K
i
 of 21 pM, 
which is well within the range of intra-
cellular Zn2+ concentrations.9 Inhibition 
of PTPs is thought to be the explanation 
for the widespread activation of tyrosine 
kinases observed in cells as a result of 
elevated levels of Zn2+.5,8 This latter event 
has major implications for diseases such 
as cancer that rely on tyrosine kinase-
driven signaling pathways for growth and 
delivers a new and novel area for drug 
development.
There are still unanswered questions 
concerning the full extent of the role of 
zinc in cell signaling. The fact that ZIP7 
needs phosphorylation in order to open 
the gate and release Zn2+ into the cyto-
sol raises the question of whether other 
ZIP channels might be gated. There are a 
number of predicted phosphorylation sites 
in other zinc transporters and channels8 
that should be investigated. Few of these 
sites are predicted to be CK2 sites, but 
several other kinases are implicated, sug-
gesting that different zinc channels may 
be controlled in different ways, helping 
to explain the diversity of zinc signaling 
functions and the presence of 14 ZIP pro-
teins in humans. There is now a need to 
identify the direct targets of zinc signals, 
including how Zn2+ released in the cell 
can selectively target particular proteins. 
Protein phosphatases4,9 and the plasma 
membrane Ca2+-ATPase10 have been 
shown to be regulated by Zn2+ at physi-
ologically relevant concentrations, but the 
exact nature of these interactions remains 
obscure. Finally, it is also unknown which 
phosphatase acts to dephosphorylate and 
presumably inactivate ZIP7, but this dis-
covery may also provide useful avenues for 
clinical exploration (Fig. 1, see page 1864).
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Figure 1. schematic illustration of the second messenger signaling pathway proposed for Zn2+. Various external stimuli cause protein kinase CK2 to 
phosphorylate endoplasmic reticulum (Er)-located zinc transporter ZiP7, which causes the gated release of Zn2+ stored within the Er through the ZiP7 
channel to create a cytosolic “zinc wave.” after phosphorylating its target, CK2 dissociates from ZiP7 and may move into the nucleus. We postulate 
that elevated Zn2+ within the cytosol may selectively inhibit tyrosine phosphatases, leading to prolonged tyrosine kinase activation and an observed 
downstream increase in pErK and paKt, resulting in cell proliferation and migration. these events, representing a short-term second messenger activ-
ity for Zn, completing within a 20 min time period, are thus temporally separated from established transcriptional impact of zinc ions, which is medi-
ated by metal transcription factor-1 (MtF-1) and is known to regulate metallothionein (Mt), glutamylcysteine synthetase (GCs) and Znt1 (sLC30a1).
